跨越障碍:利用基因编辑与生物工程技术优化癌症药物递送的策略与实践  

Overcoming Barriers: Strategies and Practices for Optimizing Cancer Drug Delivery Using Gene Editing and Biotechnology

作　　者：炼鑫淇 

机构地区：[1]北京化工大学生命科学与技术学院,北京

出　　处：《生物过程》2024年第4期196-201,共6页Bioprocess

摘　　要：本研究聚焦于癌症治疗的瓶颈——药物递送效率与精准度问题,针对当前癌症药物难以有效、精准地送达肿瘤细胞,导致治疗效果受限的现状,深入探索了基因编辑与生物工程技术在优化药物递送中的潜力。研究通过CRISPR-Cas9等基因编辑技术精准调控癌细胞基因组,结合细胞工程与纳米技术等生物工程技术,创新设计了多种高效、智能的药物递送系统。通过融合策略与个性化医疗方案的制定,本研究旨在提升药物递送的靶向性与治疗效果,并通过临床试验与监管路径的探索,推动这些技术的临床转化与应用。This study focuses on the bottleneck of cancer treatment—the efficiency and precision of drug delivery. In light of the current situation where cancer drugs are difficult to effectively and precisely deliver to tumor cells, leading to limited therapeutic effects, this study explores the potential of gene editing and biotechnology in optimizing drug delivery. The study uses CRISPR-Cas9 and other gene editing technologies to precisely regulate the cancer cell genome, and combines cell engineering and nanotechnology, among other biotechnologies, to innovatively design a variety of highly efficient and intelligent drug delivery systems. By integrating strategies and tailoring personalized medical plans, this study aims to enhance the targeting and therapeutic effects of drug delivery, and by exploring clinical trials and regulatory pathways, it seeks to promote the clinical translation and application of these technologies.

关 键 词：基因编辑 生物工程技术 癌症药物递送 策略 实践 

分 类 号：R73[医药卫生—肿瘤]